1. Exosomal miR-331-3p derived from chemoresistant osteosarcoma cells induces chemoresistance through autophagy
   Chenyang Meng et al, 2023, Journal of Orthopaedic Surgery and Research CrossRef
2. ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway
   Yong Cui et al, 2022, Aging CrossRef
3. ANXA2 and Rac1 negatively regulates autophagy and osteogenic differentiation in osteosarcoma cells to confer CDDP resistance
   Baolong Pan et al, 2023, Biochemical and Biophysical Research Communications CrossRef
4. Allicin Inhibits Osteosarcoma Growth by Promoting Oxidative Stress and Autophagy via the Inactivation of the lncRNA MALAT1-miR-376a-Wnt/β-Catenin Signaling Pathway
   Wenpeng Xie et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
5. Cytotoxic effects of walnut hull extracts against human osteosarcoma cell line (U2OS)
   Remziye Aysun Kepekci et al, 2023, Gene Reports CrossRef
6. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism
   Mehrdad Hashem et al, 2024, Non-coding RNA Research CrossRef
7. Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition
   Sunanda Singh et al, 2023, International Journal of Molecular Sciences CrossRef
8. Recent advances in glioblastoma multiforme therapy: A focus on autophagy regulation
   Mehdi Sanati et al, 2022, Biomedicine & Pharmacotherapy CrossRef
9. A fluorene derivative inhibits human hepatocellular carcinoma cells by ROS-mediated apoptosis, anoikis and autophagy
   Ritesh Urade et al, 2023, Life Sciences CrossRef
10. LncRNA SCAMP1 disrupts the balance between miR-26a-5p and ZEB2 to promote osteosarcoma cell viability and invasion
    Rong Li et al, 2022, Frontiers in Oncology CrossRef
11. Epigenetic regulation of temozolomide resistance in human cancers with an emphasis on brain tumors: Function of non-coding RNAs
    Aryan Rezaee et al, 2023, Biomedicine & Pharmacotherapy CrossRef
12. Phytochemical-Based Nanomedicine for Targeting Tumor Microenvironment and Inhibiting Cancer Chemoresistance: Recent Advances and Pharmacological Insights
    Pratikshya Sa et al, 2023, Molecular Pharmaceutics CrossRef